Please ensure Javascript is enabled for purposes of website accessibility

Why GoodRx Holdings Stock Popped Today

By Jon Quast - Jan 25, 2021 at 3:51PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

A Wall Street analyst says this is a stock to buy, but traders are likely eyeing a different reason to get in on this stock.

What happened

Shares of GoodRx Holdings (GDRX 3.73%) popped on Monday after a Wall Street analyst said the stock could go higher. However, as we'll see, there might be a little bit more to it than that. But whatever the exact catalyst, GoodRx stock was up 9% as of 2:45 p.m. EST.

So whath

Vikram Kesavabhotla with Guggenheim initiated coverage of GoodRx today, according to The Fly. You see, GoodRx has only been a public company for a few months, and it takes time for firms to start doing analysis and issuing price targets. It turns out Kesavabhotla likes GoodRx enough to start the stock off with a buy recommendation and a price target of $52 per share.

A businessman draws an exponential growth curve on a graph.

Image source: Getty Images.

This is an encouraging outlook for GoodRx shareholders. The stock fell hard a couple of months ago when Amazon announced new initiatives that seemingly intrude on GoodRx's space. Some saw it as an omen that the days of its great growth and stellar gross margins were numbered. But Kesavabhotla doesn't seem to share that negative outlook for now. 

Now what

The news of Kesavabhotla's report broke today, so this is absolutely why GoodRx stock was up today -- at least in part. Here's the other part: Stocks with high short interest are soaring today in general. And it seems to have something to do with GameStop stock. At one point today, GameStop stock was up 145%, and it's up over 300% just this month. It's an epic short squeeze that's making some traders rich in record time.

Because of this, it appears they're looking for more stocks with short-squeeze potential. And that's why stocks like Beyond Meat soared today. The same could be true of GoodRx. According to Yahoo Finance, 26% of the stock's float is sold short. And according to Nasdaq, it would take short sellers six days to cover their positions. Both of these numbers are favorable for a short squeeze, and it's doubtful this detail escaped traders' attention.

For now, this could mean that GoodRx stock will be volatile. If traders start piling in, it could spark a short squeeze that sends shares higher, at least in the short term. But if this happens, an outsized portion of GoodRx shareholders likely wouldn't be interested in holding for the long term. They'd likely just dump their shares after they've made a quick buck. So shares could be volatile to the downside as well.

Therefore, now's a good time for GoodRx shareholders to review their long-term theses to ensure they're ready to ride the coming roller-coaster.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

GoodRx Holdings, Inc. Stock Quote
GoodRx Holdings, Inc.
GDRX
$6.96 (3.73%) $0.25
Amazon.com, Inc. Stock Quote
Amazon.com, Inc.
AMZN
$116.46 (3.58%) $4.02
Nasdaq, Inc. Stock Quote
Nasdaq, Inc.
NDAQ
$159.28 (0.65%) $1.02
GameStop Corp. Stock Quote
GameStop Corp.
GME
$135.21 (-4.79%) $-6.81
Beyond Meat Stock Quote
Beyond Meat
BYND
$25.42 (-2.46%) $0.64

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
321%
 
S&P 500 Returns
111%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 06/25/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.